Tenax Therapeutics (NASDAQ:TENX) Earns Outperform Rating from Analysts at William Blair
William Blair assumed coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Free Report) in a report released on Monday morning, MarketBeat Ratings reports. The brokerage issued an outperform rating on the specialty pharmaceutical company’s stock. William Blair also issued estimates for Tenax Therapeutics’ Q3 2024 earnings at ($1.50) EPS, Q4 2024 earnings at ($1.35) EPS, […]
More Stories
Fallout Nuka Girl: Release Date, Pricing and More
Have you ever explored the world of the Fallout video gaming series? If yes, you must have probably seen the...
US to Host New Israel–Lebanon Peace Talks
By Ryan Morgan The United States will again host a set of talks between Israeli and Lebanese delegations on May...
US Fighter Jet Disables 2 Iranian Tankers in Blockade Enforcement Action: CENTCOM
By Ryan Morgan A U.S. fighter jet fired on a pair of crude oil tankers as they attempted to bypass...
OpenAI Cofounder Greg Brockman Defends Company’s For-Profit Pivot—and His Own $30 Billion Payday
By Beige Luciano-Adams In the second week of a high-profile jury trial that could have a profound impact on the...
Trump Put Tehran on the Clock
By Mehek Cooke President Donald Trump’s usual naysayers and the foreign policy class are already trying to sell his pause...
US Economy Adds 115,000 Jobs in April, Beating Market Estimates
By Andrew Moran The U.S. labor market could be showing signs of heating up after the economy topped economists’ expectations....